Trial tests safer blood pressure drug for critically ill newborns
NCT ID NCT07322133
Summary
This study is comparing two common blood pressure medications, dopamine and norepinephrine, in newborns with a serious condition that causes low blood pressure and breathing failure. The goal is to see which drug better stabilizes blood pressure without potentially worsening the baby's lung problems. The trial will enroll 30 late preterm and full-term newborns who need this type of support in the intensive care unit.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOXEMIC RESPIRATORY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC Davis Children's Hospital
RECRUITINGSacramento, California, 95817, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.